Home > Publications database > RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas. > print |
001 | 143640 | ||
005 | 20240229112601.0 | ||
024 | 7 | _ | |a 10.1007/s00401-019-02021-z |2 doi |
024 | 7 | _ | |a pmid:31062076 |2 pmid |
024 | 7 | _ | |a 0001-6322 |2 ISSN |
024 | 7 | _ | |a 1432-0533 |2 ISSN |
024 | 7 | _ | |a altmetric:60082153 |2 altmetric |
037 | _ | _ | |a DKFZ-2019-01217 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Wirthschaft, Peter |0 P:(DE-He78)7f9dda5a1b9a9ffc384598e80ade05f9 |b 0 |e First author |u dkfz |
245 | _ | _ | |a RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas. |
260 | _ | _ | |a Heidelberg |c 2019 |b Springer |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1686741925_24958 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Glioblastomas strongly invade the brain by infiltrating into the white matter along myelinated nerve fiber tracts even though the myelin protein Nogo-A prevents cell migration by activating inhibitory RhoA signaling. The mechanisms behind this long-known phenomenon remained elusive so far, precluding a targeted therapeutic intervention. This study demonstrates that the prevalent activation of AKT in gliomas increases the ER protein-folding capacity and enables tumor cells to utilize a side effect of RhoA activation: the perturbation of the IRE1α-mediated decay of SPARC mRNA. Once translation is initiated, glioblastoma cells rapidly secrete SPARC to block Nogo-A from inhibiting migration via RhoA. By advanced ultramicroscopy for studying single-cell invasion in whole, undissected mouse brains, we show that gliomas require SPARC for invading into white matter structures. SPARC depletion reduces tumor dissemination that significantly prolongs survival and improves response to cytostatic therapy. Our finding of a novel RhoA-IRE1 axis provides a druggable target for interfering with SPARC production and underscores its therapeutic value. |
536 | _ | _ | |a 319H - Addenda (POF3-319H) |0 G:(DE-HGF)POF3-319H |c POF3-319H |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Bode, Julia |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Soni, Himanshu |0 P:(DE-He78)34d5c41508d3317e721bfb593ef5948d |b 2 |u dkfz |
700 | 1 | _ | |a Dietrich, Fabio |0 P:(DE-He78)268bacdaa8869513e9bbb14f2b838ada |b 3 |u dkfz |
700 | 1 | _ | |a Krüwel, Thomas |0 P:(DE-He78)d9984bb7c7ce85fffd8c63899fb1d7fa |b 4 |u dkfz |
700 | 1 | _ | |a Fischer, Bernd |0 P:(DE-He78)5e8c9e37b2ec5e928b6170cf9ecf9770 |b 5 |u dkfz |
700 | 1 | _ | |a Knobbe-Thomsen, Christiane B |b 6 |
700 | 1 | _ | |a Rossetti, Giulia |b 7 |
700 | 1 | _ | |a Hentschel, Andreas |b 8 |
700 | 1 | _ | |a Mack, Norman |0 P:(DE-He78)e73a0a4fab40344d89d693cbe1df3109 |b 9 |u dkfz |
700 | 1 | _ | |a Schönig, Kai |b 10 |
700 | 1 | _ | |a Breckwoldt, Michael O |0 P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303 |b 11 |u dkfz |
700 | 1 | _ | |a Schmandke, André |b 12 |
700 | 1 | _ | |a Pusch, Stefan |0 P:(DE-He78)f2efee17b6ca2f790176a2c036912536 |b 13 |u dkfz |
700 | 1 | _ | |a Medenbach, Jan |b 14 |
700 | 1 | _ | |a Bendszus, Martin |b 15 |
700 | 1 | _ | |a Schwab, Martin E |b 16 |
700 | 1 | _ | |a von Deimling, Andreas |0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144 |b 17 |u dkfz |
700 | 1 | _ | |a Kool, Marcel |0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |b 18 |u dkfz |
700 | 1 | _ | |a Herold-Mende, Christel |b 19 |
700 | 1 | _ | |a Reifenberger, Guido |0 P:(DE-HGF)0 |b 20 |
700 | 1 | _ | |a Ahrends, Robert |b 21 |
700 | 1 | _ | |a Tews, Björn |0 P:(DE-He78)a33ae52a1d80b847405db3ab83b9e90d |b 22 |e Last author |u dkfz |
773 | _ | _ | |a 10.1007/s00401-019-02021-z |0 PERI:(DE-600)1458410-4 |n 2 |p 275-293 |t Acta neuropathologica |v 138 |y 2019 |x 1432-0533 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:143640 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)7f9dda5a1b9a9ffc384598e80ade05f9 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)34d5c41508d3317e721bfb593ef5948d |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)268bacdaa8869513e9bbb14f2b838ada |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)d9984bb7c7ce85fffd8c63899fb1d7fa |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)5e8c9e37b2ec5e928b6170cf9ecf9770 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)e73a0a4fab40344d89d693cbe1df3109 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)f2efee17b6ca2f790176a2c036912536 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)a33ae52a1d80b847405db3ab83b9e90d |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-319H |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Addenda |x 0 |
914 | 1 | _ | |y 2019 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ACTA NEUROPATHOL : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b ACTA NEUROPATHOL : 2017 |
920 | 1 | _ | |0 I:(DE-He78)V077-20160331 |k V077 |l AG Molekulare Mechanismen der Tumorzell-Invasion |x 0 |
920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 1 |
920 | 1 | _ | |0 I:(DE-He78)D170-20160331 |k D170 |l KKE Neuroimmunologie und Hirntumorimmunologie |x 2 |
920 | 1 | _ | |0 I:(DE-He78)B300-20160331 |k B300 |l KKE Neuropathologie |x 3 |
920 | 1 | _ | |0 I:(DE-He78)L401-20160331 |k L401 |l DKTK Essen |x 4 |
920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 5 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)V077-20160331 |
980 | _ | _ | |a I:(DE-He78)B062-20160331 |
980 | _ | _ | |a I:(DE-He78)D170-20160331 |
980 | _ | _ | |a I:(DE-He78)B300-20160331 |
980 | _ | _ | |a I:(DE-He78)L401-20160331 |
980 | _ | _ | |a I:(DE-He78)L101-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|